Literature DB >> 11590210

Phenotypic expression of familial hypobetalipoproteinemia in three kindreds with mutations of apolipoprotein B gene.

P Tarugi1, A Lonardo, C Gabelli, F Sala, G Ballarini, I Cortella, L Previato, S Bertolini, R Cordera, S Calandra.   

Abstract

We report the clinical phenotype in three kindreds with familial heterozygous hypobetalipoproteinemia (FHBL) carrying novel truncated apolipoprotein Bs (apoBs) of different sizes (apoB-8.15, apoB-33.4 and apoB-75.7). In D.A. kindred, we found three carriers of a C-deletion in exon 10 leading to the synthesis of apoB-8.15 not detectable in plasma. They showed steatorrhea and fatty liver. In N.L. kindred, the proband is heterozygous for a nonsense mutation in exon 26, leading to the formation of apoB-33.4. He had premature cerebrovascular disease and fatty liver; two apoB-33.4 carriers in this kindred showed only fatty liver. In B.E. kindred, the proband is heterozygous for a T-deletion in exon 26, which converts tyrosine at codon 3435 into a stop codon, resulting in apoB-75.7. The proband, a heavy alcohol drinker, had steatohepatitis, whereas his teetotaller daughter, an apoB-75.7 carrier, had no detectable fatty liver. This study suggests that: i) fatty liver invariably develops in FHBL carriers of short and medium-size truncated apoBs (< apoB-48), but its occurrence needs additional environmental factors in carriers of longer apoB forms; ii) intestinal lipid malabsorption develops only in carriers of short truncated apoBs, which are not secreted into the plasma; and iii) cerebrovascular disease due to premature atherosclerosis may occur even in FHBL subjects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11590210

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

1.  A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia.

Authors:  Angelo B Cefalù; James P Pirruccello; Davide Noto; Stacey Gabriel; Vincenza Valenti; Namrata Gupta; Rossella Spina; Patrizia Tarugi; Sekar Kathiresan; Maurizio R Averna
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-30       Impact factor: 8.311

Review 2.  Insights from human congenital disorders of intestinal lipid metabolism.

Authors:  Emile Levy
Journal:  J Lipid Res       Date:  2014-11-11       Impact factor: 5.922

3.  Clinical utility of genomic analysis in adults with idiopathic liver disease.

Authors:  Aaron Hakim; Xuchen Zhang; Angela DeLisle; Elif A Oral; Daniel Dykas; Kaela Drzewiecki; David N Assis; Marina Silveira; Jennifer Batisti; Dhanpat Jain; Allen Bale; Pramod K Mistry; Silvia Vilarinho
Journal:  J Hepatol       Date:  2019-04-15       Impact factor: 25.083

Review 4.  Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.

Authors:  Sebastiano Calandra; Patrizia Tarugi; Helen E Speedy; Andrew F Dean; Stefano Bertolini; Carol C Shoulders
Journal:  J Lipid Res       Date:  2011-08-23       Impact factor: 5.922

5.  Hepatosteatosis with hypobetalipoproteinemia.

Authors:  Didem Sen; Selcuk Dagdelen; Tomris Erbas
Journal:  J Natl Med Assoc       Date:  2007-03       Impact factor: 1.798

6.  Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B.

Authors:  Shumei Zhong; Antonia Lucia Magnolo; Meenakshi Sundaram; Hu Zhou; Erik F Yao; Enza Di Leo; Paola Loria; Shuai Wang; Michelle Bamji-Mirza; Lisheng Wang; C Jamie McKnight; Daniel Figeys; Yuwei Wang; Patrizia Tarugi; Zemin Yao
Journal:  J Biol Chem       Date:  2009-12-23       Impact factor: 5.157

7.  Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia.

Authors:  Enza Di Leo; Lucia Magnolo; Sandra Lancellotti; Lory Crocè; Luca Visintin; Claudio Tiribelli; Stefano Bertolini; Sebastiano Calandra; Patrizia Tarugi
Journal:  J Med Genet       Date:  2006-12-08       Impact factor: 6.318

8.  Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia.

Authors:  Paola Conca; Silvana Pileggi; Sara Simonelli; Emanuela Boer; Giuliano Boscutti; Lucia Magnolo; Patrizia Tarugi; Silvana Penco; Guido Franceschini; Laura Calabresi; Monica Gomaraschi
Journal:  J Clin Lipidol       Date:  2012-01-28       Impact factor: 4.766

9.  Familial hypobetalipoproteinemia-induced nonalcoholic steatohepatitis.

Authors:  Mindy C W Lam; Janakie Singham; Robert A Hegele; Maziar Riazy; Matti A Hiob; Gordon Francis; Urs P Steinbrecher
Journal:  Case Rep Gastroenterol       Date:  2012-07-03

Review 10.  Human plasma protein N-glycosylation.

Authors:  Florent Clerc; Karli R Reiding; Bas C Jansen; Guinevere S M Kammeijer; Albert Bondt; Manfred Wuhrer
Journal:  Glycoconj J       Date:  2015-11-10       Impact factor: 2.916

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.